Research Articles | Page 27 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes May 2019 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes May 2019 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience Sep 2020 Leukemia & Lymphoma Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis Jun 2019 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Raising the bar for lower-risk myelodysplastic syndromes Jun 2023 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Following in the footsteps of acute myeloid leukemia: are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes? Oct 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Following in the footsteps of acute myeloid leukemia: are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes? Oct 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Eat and be healthy: nutritional status in myelodysplastic syndromes Jul 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents Oct 2019 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy Oct 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)